Xtx Topco LTD Rocket Pharmaceuticals, Inc. Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 63,634 shares of RCKT stock, worth $601,341. This represents 0.07% of its overall portfolio holdings.
Number of Shares
63,634
Previous 15,503
310.46%
Holding current value
$601,341
Previous $286,000
179.37%
% of portfolio
0.07%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding RCKT
# of Institutions
244Shares Held
108MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$167 Million3.63% of portfolio
-
Wellington Management Group LLP Boston, MA14MShares$132 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$62.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$58.5 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$49.1 Million1.26% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $715M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...